Champions Oncology Inc.
9.62
-0.05 (-0.52%)
At close: Jan 15, 2025, 11:38 AM

Champions Oncology Inc. Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for CSBR stock have an median target of 8, with a low estimate of 8 and a high estimate of 8. The median target predicts a decrease of -16.84% from the current stock price of 9.62.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $8 $8 $8 $8
Change -16.84% -16.84% -16.84% -16.84%

AI Analyst Report

According to 1 stock analyst, the rating for Champions Oncology Inc. is "Strong Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Mar 24Sep 24Dec 24
Strong Buy 001
Buy 010
Hold 100
Sell 000
Strong Sell 000
Total 1 1 1

Financial Forecast this Year

Revenue This Year
56.10M
from 50.16M
Increased by 11.9%
Revenue Next Year
61.80M
from 56.10M
Increased by 10.2%
EPS This Year
0.21
from -0.54
Increased by 61.1%
EPS Next Year
0.24
from 0.21
Increased by 14.3%